Clinical Trial Update: A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 basket trial evaluating customized autologous TCR-T cell therapies across multiple locally advanced or metastatic solid tumors, sponsored by TScan Thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Squamous Cell Carcinoma
• Cervical Cancer
• Head and Neck Cancer
• Oropharyngeal Squamous Cell Carcinoma
• Ovarian Cancer
• Penile Squamous Cell Carcinoma
• Vaginal Cancer
• Vulvar Squamous Cell Carcinoma

Drugs mentioned

• Customized autologous TCR-T cell therapy (autologous T-cell receptor-engineered T cells)

Snippet

Sponsor: TScan Therapeutics, Inc. | Conditions: Head and Neck Cancer, Cervical Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING